Skip to main content
. 2020 May 19;136(11):1284–1297. doi: 10.1182/blood.2019003959

Figure 3.

Figure 3.

EFS, according to Myc protein expression. Kaplan-Meier curves of EFS in evaluable Myc+ vs Myc cases in all study-eligible patients with aggressive HIV-NHL (n = 51) (A); all DLBCL (n = 36) (B); non-GCB (n = 19) (C) and GGB (n = 17) (D) DLBCL subtypes; and PBL (9 of 9) (E) and PEL (3 of 3) (F).